Contact

location_on

18, rue Jean Perrin
31100 Toulouse
France

Séverine Hountondji
Business Development Director

About us

GTP Bioways is a CDMO specialized in process development and GMP manufacturing of innovative therapeutic products (antibodies, recombinant proteins, antibody-drug conjugates and nanomedicines).
The GTP Bioways group comprises several expert development and production units based in Toulouse, Labège and Issoire.

Business offer

For 20 years, GTP Bioways' teams have been supporting biopharmaceutical companies in the development of their innovative molecules, from R&D through to clinical trials, thanks to flexible GMP production and aseptic filling capabilities. Thanks to its unique expertise in process development, particularly for complex biomolecules, we are able to offer a customized approach adapted to the challenges, constraints and stage of development of each project.
GTP Bioways has 4 GMP manufacturing lines (drug substance and drug product) based in France.

Activities

    Categories

    • Service

    Therapeutic applications

    • Cardiology
    • Genetic Diseases
    • Oncology
    • Nervous Central System
    • Hematology
    • Infectiology
    • Immunology
    • Ophthalmology
    • Inflammation
    • Other

    Expertises

    Directory of Antibodies, Recombinant proteins and others
    • Immunotherapy lead optimization
    • Engineering
    • ADC
    • Linkers
    • Payloads
    • Protein scaffolds
    • Fragments
    • Multi-, bispecific
    • Fc-fusion proteins
    • Indication Prioritization
    • Antibody humanization
    • Affinity maturation
    • Proof of concept
    • Pharmacology potency
    • Exploratory toxicology
    • in-vitro & ex-vivo models
    • in-vivo models
    • Cell expansion
    • Gas permeable bags
    • G-Rex bioreactors
    • Wave-mixed bioreactors
    • CMC
    • GLP compliance
    • GLP compliance
    • Master Cell Bank
    • Production
    • Cell Line development
    • Clone selection
    • Characterization
    • Storage
    • Analytical development
    • Cell Culture
    • Media composition
    • Bioreactor conditions
    • Gene modification / Transduction
    • Retroviral & lentiviral vectors
    • Cell expansion
    • Wave-mixed bioreactors
    • Stirred tank reactors
    • Bioproduction
    • Batches production type
    • Mammalian
    • Insect
    • Yeast
    • Bacterial
    • GLP compliance
    • GMP compliance
    • Pilot Batches
    • Tests
    • Optimization
    • Scale-Up process
    • Process optimization & validation
    • Volume
    • Preclinical / Tox
    • Low volume (< 200 L)
    • High volume (200 – 2000 L)
    • Commercial
    • USP (Scale-Up)
    • Cell expansion
    • Inoculation
    • Low volume containers to Bioreactors
    • DSP (Recovery)
    • Harvest
    • Filtration
    • Purification
    • Fill & Finish
    • Aseptic filling
    • Batch release
    • Storage matter
    • Quality assurance, quality control & analytical process
    • Stability Assessment
    • Physical & chemical profile
    • Shear/shaking
    • Viscosity
    • Photostability
    • pH
    • Freeze/thaw
    • Heat/degradation
    • Aggregation
    • Cell line analytical development
    • Host cell proteins
    • Viral clearance
    • Contaminants detection
    • Biosafety & Bioanalysis
    • Impurities detection
    • Bioproduction analytical test
    • Monitoring
    • Characterization
    • Batch consistency
    • Batch release test
    • Chemical, physical, biological test
    • Quality control test support
    • Formulation
    • Formulation
    • Dose
    • Stability
    • Excipients
    • Adjuvants
    • Sterilization
    • Lyophilization
    • Storage stability
    • Clinical trials
    • Phase I
    • Phase II
    • Phase III
Français English